Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone

作者: N. Ghanem , M. Uhl , I. Brink , O. Schäfer , T. Kelly

DOI: 10.1016/J.EJRAD.2005.01.016

关键词: Bone marrowPositron emission tomographyIn patientNuclear medicineAxial skeletonRadiologyScintigraphyMetastasisMedicineCancerPET-CT

摘要: Abstract The initial localization of metastases in the bone patients with solid tumors has a relatively good prognosis comparison visceral metastasization. early detection marrow allows for rapid initiation therapy and subsequent reduction morbidity rate. Modern MRI is superior to 30-year-old skeletal scintigraphy respect sensitivity, specificity, as well extent osteal metastasis. provides sustantial, therapy-relevant additional information. MSCT plays an important role management cancer clinical routine gives excellent survey axial skeleton by demonstrating osteolytic osteoblastic metastases. Extensive comparative studies 18 F-FDG-PET F-fluoride-PET have not yet been carried out. Whole body very promising new staging method oncological diagnosis adoption FDG side PET-CT image fusion two one PET/CT examinations appears be slightly less sensitive whole Larger, prospective multicenter are necessary establish these new, methods

参考文章(76)
Heffelfinger-Juttner J, Nystrom Js, Weiner Jm, Irwin Le, Bateman, Wolf Rm, Metastatic and histologic presentations in unknown primary cancer. Seminars in Oncology. ,vol. 4, pp. 53- 58 ,(1977)
A. Bockisch, T. Beyer, G. Antoch, P. Veit, S. M�ller, R. Pink, S. Rosenbaum, H. K�hl, [Principles of PET/CT and clinical application]. Radiologe. ,vol. 44, pp. 1045- 1054 ,(2004) , 10.1007/S00117-004-1122-9
Bockisch A, Antoch G, Vogt Fm, Ruehm Sg, [Whole-body tumor staging: MRI or FDG-PET/CT?]. Radiologe. ,vol. 44, pp. 882- ,(2004) , 10.1007/S00117-004-1093-X
Tiling R, Hahn K, Baur-Melnyk A, Schoenberg So, Schmidt Gp, Reiser Mf, [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system]. Radiologe. ,vol. 44, pp. 889- ,(2004) , 10.1007/S00117-004-1102-0
G.P. Schmidt, A. Baur-Melnyk, R. Tiling, K. Hahn, M.F. Reiser, S.O. Schoenberg, Hochauflösendes Ganzkörpertumorstaging unter Verwendung paralleler Bildgebung im Vergleich zur PET-CT Radiologe. ,vol. 44, pp. 889- 898 ,(2004) , 10.1007/S00117-004-1102-0
G. Antoch, F.M. Vogt, A. Bockisch, S.G. Ruehm, Ganzkörpertumorstaging: MRT oder FDG-PET/CT? Radiologe. ,vol. 44, pp. 882- 888 ,(2004) , 10.1007/S00117-004-1093-X
Christiane Franzius, Joachim Sciuk, Heike E. Daldrup-Link, Heribert Jürgens, Otmar Schober, FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 27, pp. 1305- 1311 ,(2000) , 10.1007/S002590000301
June-Key Chung, Young So, Jae Sung Lee, Chang Woon Choi, Sang Moo Lim, Dong Soo Lee, Sung Woon Hong, Yeo Kyu Youn, Myung Chul Lee, Bo Youn Cho, None, Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. The Journal of Nuclear Medicine. ,vol. 40, pp. 986- 992 ,(1999)
Heike E. Daldrup-Link, Christiane Franzius, Thomas M. Link, Daniela Laukamp, Joachim Sciuk, Heribert Jürgens, Otmar Schober, Ernst J. Rummeny, Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. American Journal of Roentgenology. ,vol. 177, pp. 229- 236 ,(2001) , 10.2214/AJR.177.1.1770229
G J Cook, S Houston, R Rubens, M N Maisey, I Fogelman, Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. Journal of Clinical Oncology. ,vol. 16, pp. 3375- 3379 ,(1998) , 10.1200/JCO.1998.16.10.3375